Xencor Inc — Director's Dealing 2019

Feb 8, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Inmune Bio, Inc. (INMB)
CIK: 0001711754
Period of Report: 2019-02-01

Reporting Person: Xencor Inc (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1585000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock option (right to buy)	$7.80	2027-11-15	Common Stock (108000)		Direct

Footnotes

F1: The shares subject to the option vest over 36 months beginning on April 3, 2018.